The issuer is solely responsible for the content of this announcement.

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa ...

Edenlux builds wearable tech to protect and train your eyes, inspired by its founder’s personal vision recovery.

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...